STAAR Surgical’s (STAA) “Outperform” Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of STAAR Surgical (NASDAQ:STAA – Free Report) in a research note published on Tuesday morning,Benzinga reports. The brokerage currently has a $40.00 target price on the medical instruments supplier’s stock. Several other equities analysts also recently commented on the stock. Piper Sandler boosted their target price on shares […]
7 Aug 06:36 · The Markets Daily